Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis.

ESMO open·2022
Same author

Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota.

Clinical and experimental immunology·2022
Same author

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.

Gynecologic oncology·2020
Same author

Interactions of the microbiota with the mucosal immune system.

Clinical and experimental immunology·2019
Same author

CD200R deletion promotes a neutrophil niche for Francisella tularensis and increases infectious burden and mortality.

Nature communications·2019

Related Experiment Video

Updated: May 21, 2026

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine
09:25

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine

Published on: May 21, 2012

Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells.

V Cerovic1, S A Houston, C L Scott

  • 1Institute for Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. vuk.cerovic@glasgow.ac.uk

Mucosal Immunology
|June 22, 2012
PubMed
Summary

Two new subsets of intestinal dendritic cells (DCs) were discovered in lymph. These CD103(-) DCs rapidly generate gut-homing effector T cells, offering potential targets for treating intestinal inflammation and developing oral vaccines.

More Related Videos

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors
08:39

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors

Published on: January 7, 2019

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Related Experiment Videos

Last Updated: May 21, 2026

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine
09:25

Isolation and Characterization of Dendritic Cells and Macrophages from the Mouse Intestine

Published on: May 21, 2012

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors
08:39

Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors

Published on: January 7, 2019

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Intestinal dendritic cells (DCs) are crucial for initiating gut immunity and tolerance.
  • Research has primarily focused on CD103-expressing intestinal DCs.
  • Understanding the full spectrum of intestinal DC subsets is vital for immune regulation.

Purpose of the Study:

  • To identify and characterize novel subsets of intestinal dendritic cells in lymph.
  • To investigate the functional properties of these newly identified DC subsets, particularly their interaction with T cells.
  • To explore the potential therapeutic implications of these DCs in gut inflammation and vaccine development.

Main Methods:

  • Analysis of intestinal lymph to identify distinct dendritic cell populations.
  • Phenotypic characterization of CD103(-) dendritic cell subsets using flow cytometry.
  • Functional assays to assess the capacity of these DCs to prime and differentiate naive T cells.
  • Evaluation of T cell responses, including the induction of specific cytokine production (IFN-γ, IL-17).

Main Results:

  • Discovery of two previously undescribed CD103(-) dendritic cell subsets in intestinal lymph.
  • These CD103(-) DCs are responsive to Flt3 stimulation and prime naive T cells, conferring a gut-homing phenotype.
  • A specific subset, CD103(-) CD11b(+) CX(3)CR1(int) lymph DCs, uniquely induces differentiation of both IFN-γ and IL-17 producing effector T cells without overt stimulation.
  • This priming represents a novel mechanism for rapid effector T cell generation in the gut.

Conclusions:

  • Intestinal lymph harbors distinct CD103(-) dendritic cell subsets with unique immune-priming capabilities.
  • The CD103(-) CD11b(+) CX(3)CR1(int) DC subset offers a novel pathway for rapid effector T cell responses in the gut.
  • These findings highlight potential therapeutic targets for intestinal inflammation and the development of oral vaccines.